188 related articles for article (PubMed ID: 6344715)
1. Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up.
Carette S; Klippel JH; Decker JL; Austin HA; Plotz PH; Steinberg AD; Balow JE
Ann Intern Med; 1983 Jul; 99(1):1-8. PubMed ID: 6344715
[TBL] [Abstract][Full Text] [Related]
2. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
Felson DT; Anderson J
N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
[TBL] [Abstract][Full Text] [Related]
4. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.
Dinant HJ; Decker JL; Klippel JH; Balow JE; Plotz PH; Steinberg AD
Ann Intern Med; 1982 Jun; 96(6 Pt 1):728-36. PubMed ID: 7046543
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
6. Treatment of lupus nephritis: a meta-analysis of clinical trials.
Bansal VK; Beto JA
Am J Kidney Dis; 1997 Feb; 29(2):193-9. PubMed ID: 9016889
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
Decker JL; Klippel JH; Plotz PH; Steinberg AD
Ann Intern Med; 1975 Nov; 83(5):606-15. PubMed ID: 1106278
[TBL] [Abstract][Full Text] [Related]
8. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only.
Steinberg AD; Steinberg SC
Arthritis Rheum; 1991 Aug; 34(8):945-50. PubMed ID: 1859488
[TBL] [Abstract][Full Text] [Related]
9. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
Ginzler E; Diamond H; Guttadauria M; Kaplan D
Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic drug treatment of lupus nephritis.
Donadio JV; Holley KE; Ilstrup DM
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive agents in lupus nephritis: a critical analysis.
Wagner L
Medicine (Baltimore); 1976 May; 55(3):239-50. PubMed ID: 775253
[No Abstract] [Full Text] [Related]
12. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
13. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
Barnett EV; Dornfeld L; Lee DB; Liebling MR
J Rheumatol; 1978; 5(3):275-87. PubMed ID: 372523
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
Purice S; Ghelerter L; Matei I; Brunazian G
Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
[No Abstract] [Full Text] [Related]
15. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide.
Donadio JV; Holley KE; Ferguson RH; Ilstrup DM
Mayo Clin Proc; 1976 Aug; 51(8):484-94. PubMed ID: 950801
[TBL] [Abstract][Full Text] [Related]
16. Sequential therapies for proliferative lupus nephritis.
Contreras G; Pardo V; Leclercq B; Lenz O; Tozman E; O'Nan P; Roth D
N Engl J Med; 2004 Mar; 350(10):971-80. PubMed ID: 14999109
[TBL] [Abstract][Full Text] [Related]
17. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in lupus nephritis. Contribution of renal histologic data.
Austin HA; Muenz LR; Joyce KM; Antonovych TA; Kullick ME; Klippel JH; Decker JL; Balow JE
Am J Med; 1983 Sep; 75(3):382-91. PubMed ID: 6351607
[TBL] [Abstract][Full Text] [Related]
19. Celebrating the ACP centennial: from the Annals archive.
Cotton D
Ann Intern Med; 2015 Jan; 162(1):70. PubMed ID: 25560715
[No Abstract] [Full Text] [Related]
20. Progression and remission of renal disease in the Lupus Nephritis Collaborative Study. Results of treatment with prednisone and short-term oral cyclophosphamide.
Levey AS; Lan SP; Corwin HL; Kasinath BS; Lachin J; Neilson EG; Hunsicker LG; Lewis EJ
Ann Intern Med; 1992 Jan; 116(2):114-23. PubMed ID: 1727614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
